Nephros Inc

Nephros Inc. pushes its hemodiafiltration tech into Western Europe, eyeing growth for end‑stage renal disease patients while preparing investors for Q4 2025 results.

Nephros Inc. has released its latest financial results, showing a volatile stock price and a substantial valuation gap, but the company remains committed to expanding its product reach and improving patient outcomes.